Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MACOP-B regimen

Known as: Methotrexate-Adriamycin-Cytoxan-Oncovin-Prednisone-Bleomycin Regimen 
A regimen consisting of methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine and prednisone, used to treat aggressive forms of non… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
An extensive analysis of the reliability of positron emission tomography (PET) after induction treatment in patients with Hodgkin… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
Highly Cited
1999
Highly Cited
1999
To evaluate the efficacy of a combined modality treatment (MACOP-B plus mediastinal radiotherapy) and the advantages of Gallium… Expand
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Highly Cited
1997
Highly Cited
1997
BACKGROUND We compared a regimen of six chemotherapeutic agents administered sequentially at high doses, followed by… Expand
Highly Cited
1994
Highly Cited
1994
PURPOSE To compare complete response rates, time to failure, survival, and toxicity for patients with intermediate-grade non… Expand
Highly Cited
1993
Highly Cited
1993
BACKGROUND CHOP is a first-generation, combination-chemotherapy regimen consisting of cyclophosphamide, doxorubicin, vincristine… Expand
Highly Cited
1993
Highly Cited
1993
PURPOSE To evaluate the clinical features of presentation, the morphologic and immunohistochemical pattern, the modality of… Expand
Highly Cited
1991
Highly Cited
1991
One hundred twenty-six patients with diffuse large-cell lymphoma were treated with methotrexate with leucovorin, doxorubicin… Expand
Highly Cited
1990
Highly Cited
1990
While diffuse large-cell lymphoma (DLCL) is considered to be highly curable with current therapy, treatment failures are observed… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Highly Cited
1988
Highly Cited
1988
Between 1981 and 1986, we treated 179 newly diagnosed patients with advanced-stage malignant lymphoma or related conditions with… Expand
Highly Cited
1985
Highly Cited
1985
Between April 1981 and May 1984, 61 patients with advanced diffuse large-cell lymphoma completed treatment with MACOP-B… Expand